The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients

There are various melanoma treatment strategies that are based on immunological responses, among which immune checkpoint inhibitors (ICI) are relatively novel form. Nowadays, anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and anti-programmed death-1 (PD-1) antibodies represent a standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomela, Katarzyna, Pietrzak, Bernadeta, Schmidt, Marcin, Mackiewicz, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600343/
https://www.ncbi.nlm.nih.gov/pubmed/32992737
http://dx.doi.org/10.3390/life10100219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600343/
https://www.ncbi.nlm.nih.gov/pubmed/32992737
http://dx.doi.org/10.3390/life10100219

Ejemplares similares